Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sujay Ratna has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Barbara Kiesel

    Department of Neurosurgery, Medical University Vienna, Vienna, Austria

    3 shared publications
  • David Reichert

    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria

    3 shared publications
  • Dimitris Placantonakis

    Department of Neurosurgery, NYU Grossman School of Medicine, New York, USA

    3 shared publications
  • Donato Pacione

    Department of Neurosurgery, NYU Grossman School of Medicine, New York, USA

    3 shared publications
  • Hannah Weiss

    Department of Neurosurgery, NYU Grossman School of Medicine, New York, USA

    3 shared publications
  • Jay Trautman

    Invenio Imaging, Inc, Santa Clara, USA

    3 shared publications

Latest Publications

  • The Statistical Fragility of Saline Nasal Irrigation for Rhinosinusitis: A Systematic Review

    by Ronit Sethi, Kaan Oral, Rahul Guda, Shiven Sharma, Sujay Ratna, Olivia First, Shreya Deshmukh, Chris Choi, Mohemmed N. Khan

    Objective: To assess the statistical fragility of randomized controlled trials (RCTs) evaluating high‐volume saline nasal irrigation (SNI) for rhinosinusitis using fragility analysis. Data Sources: PubMed, MEDLINE, and Embase were searched for RCTs published between May 1976 and January 2026. Review Methods: This study was reported as per PRISMA guidelines. RCTs that compared high‐volume SNI to non‐irrigation standard care for acute, recurrent, or chronic rhinosinusitis, and reported ≥ 1 dichotomous outcome, were included. Fragility index (FI), the minimum number of event reversals needed to alter statistical significance, and fragility quotient (FQ), FI normalized to sample size, were calculated for statistically significant dichotomous outcomes. Reverse FI (rFI) and reverse FQ (rFQ) were calculated for non‐significant outcomes. Results: Eight RCTs were included, yielding 38 dichotomous outcomes. Eight outcomes (21.1%) were statistically significant. The overall combined median FI was 5 (FQ 0.062), with similar FI values between significant and non‐significant outcomes. In over one‐fifth of outcomes, loss to follow‐up exceeded FI. Analysis of principal dichotomous outcomes from studies demonstrated a median FI of 6 (FQ 0.092), with five of eight (62.5%) outcomes non‐significant. Conclusion: RCTs evaluating SNI for rhinosinusitis exhibit moderate‐to‐high statistical fragility, with small outcome changes capable of reversing study conclusions. Because fragility analysis was limited to dichotomous outcomes while many primary endpoints were continuous, our findings should be interpreted as complementary rather than comprehensive appraisals of RCTs. Future RCTs with larger sample sizes, reduced bias, and pre‐specified fragility considerations are needed to better define the clinical role of SNI.

  • Nationwide Analysis of Head and Neck Imaging for Bell's Palsy: Insights From Healthcare Claims

    by Sujay Ratna, Rahul Sharma, Eric Gong, Joshua Rosenberg, Mingyang Gray

    Introduction: Professional society guidelines recommend against routine diagnostic imaging for suspected Bell's palsy at initial presentation. This study examines national trends in imaging use, adherence to guidelines, and the utility of CT and MRI in treatment practices. Methods: A retrospective cohort study of 35,942 adult Bell's palsy patients using ICD‐9‐CM and ICD‐10‐CM diagnosis codes from 2016 to 2021 was conducted. These patients were continuously enrolled for ≥ 1 year in the employer‐sponsored MarketScan commercial or Medicare outpatient and prescription drugs claims data. The main outcomes of interest were CT and MRI scan usage at or after the diagnosis date. Results: CT scans were performed in 27% of patients (median time: 3 days), while MRI was performed in 25% (median time: 36 days). Within 30 days of their index claim, 16% underwent CT scanning and 12% underwent MRI. Patients on combination therapy (steroids and antivirals) had significantly higher rates of early imaging (CT: 38% vs. 25%, p < 0.001; MRI: 19% vs. 17%, p < 0.001) compared to monotherapy. CT imaging within 30 days of index diagnosis was strongly associated with combination therapy (OR = 3.49, 95% CI = 3.28–3.73, p < 0.001), as was early MRI to a lesser extent (OR = 1.26, 95% CI = 1.17–1.35, p < 0.001). Imaging was most frequent in acute care settings, and median costs rose significantly with dual‐modality imaging ( p < 0.001). Conclusion: CT and MRI are frequently used in Bell's palsy despite guideline recommendations, especially in patients receiving combination therapy. This study finds an association between diagnostic imaging for Bell's palsy and combination therapy, highlighting opportunities to reduce unnecessary testing and promote guideline‐based care. Level of Evidence: 3.


  • Open Access

    Trends and Innovation in Rhinology: A Bibliometric Analysis of Patent Activity (1974-2024)

    by Shiven Sharma, Omar Alani, Dany Alkurdi, Prabhjot Singh, Olivia First, Bashar Zaidat, Torin Thielhelm, Sujay Ratna, Keshav Sharma, Dev Patel, et al.

    Objectives: This study aims to review and analyze the most cited patents in the field of rhinology, identifying technological trends and patterns of development. Study Design: Cross-sectional analysis. Setting: National database. Methods Patents were gathered from the Lens database by identifying titles, abstracts, and claims that contain the term “rhinology” and were classified under the Cooperative Patent Classification (CPC) code A61. After manual curation corrected for duplicate and extraneous patents, the remaining patents were ranked by the number of forward citations. The top 100 patents were put into five subcategories: “Balloon and Catheter-Based Treatment,” “Drug Delivery Systems and Therapeutics,” “Non-Surgical Diagnostic Devices,” “Sinonasal Ablation Techniques,” and “Surgical Instruments and Methods.” Results With the initial search criteria, 1,440 patents were identified, and 521 patents were retained after the manual screening process. Analysis of the top 100 patents revealed that most patents had priority years between 2000-2010. Sixty-four percent of these patents were active at the time of the study. Non-Surgical Diagnostic Devices was the largest subcategory, followed by Balloon and Catheter-Based Treatment, and then Sinonasal Ablation Techniques. Balloon and Catheter-Based Treatments and Sinonasal Ablation Techniques comprised the majority of the first quintile of patents by citation number. Linear regression showed a weak correlation between priority year and patent rank by citation (Pearson’s R = 0.34, R-squared = 0.12). Conclusion This analysis highlights the ongoing evolution in rhinologic technology, particularly in Non-Surgical Diagnostic Devices. Additionally, it serves as a resource for informing future research and development efforts within this field.

  • Evaluating Treatment Patterns in Bell's Palsy Using Nationwide Employer‐Sponsored Healthcare Claims

    by Sujay Ratna, Shaun Edalati, Yehia Elkersh, Parul Agarwal, Joshua Rosenberg, Mingyang Gray

    Objective: Professional society guidelines provide clear recommendations regarding the use of high‐dose steroids and/or antiviral therapy for Bell's palsy patients. This study evaluates national trends in the care of Bell's palsy patients and identifies current treatments.Methods: A retrospective cohort study of adult Bell's palsy patients was conducted using ICD‐9‐CM and ICD‐10‐CM diagnosis codes from 2013 to 2020. These patients were continuously enrolled in the employer‐sponsored MarketScan commercial or Medicare outpatient and prescription drug claims data for at least 1 year. The main outcome of interest was prescription rates of high‐dose steroids and antivirals after the diagnosis date.Results: In this cohort of 66,708 adult Bell's palsy patients, 29,824 (44.7%) received no treatment. 22,736 (34.1%) received combination therapy, 11,866 (17.8%) received steroids only, and 2282 (3.4%) received antivirals only. Males were more likely to receive combination therapy. 51.9% of Bell's palsy patients in this cohort received the AAO‐recommended treatment of steroids within 72 h of diagnosis. Patients in the Southern and Western United States were more commonly prescribed combination therapy. Comorbidities such as cerebrovascular disease and symptoms like ear pain were associated with a higher likelihood of receiving combination therapy. Treatment initiation, particularly for steroids, occurred on the index date, first insurance claim, in 94.56% of cases.Conclusion: Only 51.9% of Bell's palsy patients in this cohort received the AAO‐recommended treatment with high‐dose steroids with or without antiviral therapy. This research provides valuable insights into the real‐world management of Bell's palsy, emphasizing the need for adherence to established treatment guidelines.Level of Evidence: N/A


  • Open Access

    Enhanced Photosensitivity and Surfactant Resistance in Nanopolymersome Membranes as a Function of Gold Nanoparticle Incorporation

    by Regina L. Salzer, Ajay N. Shah, Cory J. Trout, Abby R. Robinson, Sujay Ratna, Sean M. O’mAlley, Julianne C. Griepenburg

    Polymersomes hold great promise as carrier vesicles for the encapsulation and delivery of cargo. Self-assembly of amphiphilic diblock copolymers into spherical vesicles result in two compartments for encapsulation: an aqueous lumen and a bilayer membrane. Herein, it is demonstrated that dodecanethiol-functionalized gold nanoparticles (AuNPs) can be loaded within the hydrophobic region of the bilayer membrane of polybutadiene-b-poly­(ethylene oxide) nanopolymersomes as photosensitizers. This is shown to render vesicles responsive to picosecond pulsed irradiation at a wavelength congruent with the localized surface plasmon resonance of the gold nanoparticles. Membrane disruption is demonstrated to scale with laser pulse energy and shows a strong enhancement with nanoparticle incorporation even at the low end of the concentration range. Nanoparticle concentration is also shown to increase polymersome stability in the presence of nonionic surfactants such as polysorbate 20 and ionic surfactants such as sodium dodecyl sulfate. In addition, a comparative analysis is performed between dynamic light scattering and cryo-transmission electron microscopy vesicle size results whereby an inference is made between sample composition and analytical method.


  • Mucocutaneous Leishmaniasis Rhinology Complications: A Rare Presentation

    by Sujay Ratna, Shaun Edalati, Mohamed Darwish, Mingyang Gray, Alfred Marc Iloreta

    Objective: This case report presents a unique manifestation of Mucocutaneous Leishmaniasis (MCL) in a 56-year-old woman with chronic nasal symptoms. Initially diagnosed with chronic sinusitis and septal perforation, the patient’s history of a childhood sandfly bite and subsequent episodes of Leishmaniasis, revealed after nasal surgery, provided crucial information for accurate diagnosis. Methods: A retrospective review was conducted on this patient’s electronic medical record. Results: The patient’s life-long struggle with nasal obstruction, congestion, and a septal perforation initially masked the underlying MCL. Sinus surgery and persistent symptoms further complicated the diagnostic process. Only after postoperative complications, including grainy skin texture extending into the nasal passages, did the patient recall the sandfly bite, prompting reevaluation and diagnosis of MCL. The case highlights the challenges of diagnosing MCL due to its varied presentation and potential mimicry of other chronic nasal conditions. It emphasizes the importance of thorough patient history-taking, especially when symptoms are atypical or persistent. Additionally, the report underscores the potential for unexpected postoperative complications in MCL patients and the need for vigilance in recognizing and assessing them. Conclusion: This case contributes to the understanding of MCL’s diverse clinical presentation and the importance of early diagnosis and multidisciplinary management for prompt intervention and improved outcomes.

  • Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopy

    by Mustafa Nasir-Moin, Lisa Irina Wadiura, Vlad Sacalean, Devin Juros, Misha Movahed-Ezazi, Emily K. Lock, Andrew Smith, Matthew Lee, Hannah Weiss, Michael Müther, et al.

    The most widely used fluorophore in glioma-resection surgery, 5-aminolevulinic acid (5-ALA), is thought to cause the selective accumulation of fluorescent protoporphyrin IX (PpIX) in tumour cells. Here we show that the clinical detection of PpIX can be improved via a microscope that performs paired stimulated Raman histology and two-photon excitation fluorescence microscopy (TPEF). We validated the technique in fresh tumour specimens from 115 patients with high-grade gliomas across four medical institutions. We found a weak negative correlation between tissue cellularity and the fluorescence intensity of PpIX across all imaged specimens. Semi-supervised clustering of the TPEF images revealed five distinct patterns of PpIX fluorescence, and spatial transcriptomic analyses of the imaged tissue showed that myeloid cells predominate in areas where PpIX accumulates in the intracellular space. Further analysis of external spatially resolved metabolomics, transcriptomics and RNA-sequencing datasets from glioblastoma specimens confirmed that myeloid cells preferentially accumulate and metabolize PpIX. Our findings question 5-ALA-induced fluorescence in glioma cells and show how 5-ALA and TPEF imaging can provide a window into the immune microenvironment of gliomas.


  • The impact of frailty on facial nerve recovery following Bell's palsy

    by Sujay Ratna, Vivek Annadata, David W. Chou, Joshua D. Rosenberg, Mingyang L. Gray


  • Open Access

    Localization of protoporphyrin IX in glioma patients with paired stimulated Raman histology and two-photon excitation fluorescence microscopy

    by Mustafa Nasir-Moin, Lisa Wadiura, Devin Juros, Misha Movahed-Ezazi, Matthew Lee, Hannah Weiss, Michael Müther, Daniel Alber, Sujay Ratna, Camila Fang, et al.

    Fluorescence guidance is widely utilized to improve the precision of cancer surgery. 5-aminolevulinic acid, the most widely used fluorophore in glioma surgery, is thought to cause selective accumulation of fluorescent protoporphyrin IX (PpIX) in tumor cells. 5-aminolevulinic acid is highly specific for densely tumor-infiltrated tissue but less effective for visualizing the tumor periphery. To improve clinical detection of PpIX, we developed a microscope to perform paired stimulated Raman histology and two-photon excitation fluorescence microscopy (TPEF) and validated it in 175 fresh tumor specimens from 75 high-grade glioma patients across three institutions. Here, we demonstrate that intracellular PpIX accumulation occurs most prominently in histiocytic, rather than neoplastic, appearing cells. Spatially resolved metabolomics, transcriptomics and RNA sequencing revealed that PPIX is most avidly concentrated in tumor associated macrophages. There was no correlation between the degree of tissue cellularity and PpIX concentration across all imaged specimens (R=-0.21). Our findings encourage reconsideration of the existing theory of 5-ALA-induced glioma cell fluorescence and demonstrate how 5-ALA and TPEF imaging can provide a window into the immune microenvironment of human gliomas.


  • SURG-24. QUANTITATIVE ANALYSIS OF TUMOR CELL DENSITY AND PROTOPORPHYRIN IX FLOURESCENCE IN GLIOMA PATIENTS USING PAIRED STIMULATED RAMAN HISTOLOGY AND TWO-PHOTON EXCITATION FLUORESCENCE MICROSCOPY

    by Mustafa Nasir-Moin, Lisa Irina Wadiura, Devin Juros, Misha Movahed-Ezazi, Matthew Lee, Hannah Weiss, Michael Müther, Daniel Alber, Sujay Ratna, Camila Fang, et al.

    Fluorescence guidance is widely utilized to improve the precision of cancer surgery. 5-aminolevulinic acid, the most widely used fluorophore in glioma surgery, is thought to cause selective accumulation of fluorescent protoporphyrin IX (PpIX) in tumor cells by exploiting pathologic alterations in heme biosynthetic pathways. PpIX-induced fluorescence is highly specific for densely tumor-infiltrated tissue but less effective for visualizing the tumor periphery. To improve clinical detection of PpIX, we developed a microscope to perform paired stimulated Raman histology and two-photon excitation fluorescence microscopy (TPEF) and validated it in 175 fresh, unprocessed core tumor specimens from 75 high-grade glioma patients and three central nervous system lymphoma patients across three institutions. Surprisingly, intracellular PpIX accumulation was observed primarily in cells with histiocytic, rather than neoplastic morphology, and the number of cells concentrating PpIX within the cytoplasm was associated with the abundance of CD163 positive cells (p< 0.02). There was no correlation between the degree of tumor cellularity and the concentration of PpIX across all imaged specimens (R=-0.21). Our findings encourage reconsideration of the existing theory of 5-ALA-induced tumor cell fluorescence in gliomas and demonstrate how 5-ALA and TPEF imaging can provide a window into the immune microenvironment of human gliomas.